In other recent news, Sotera Health has reported several significant developments. The company has seen an uptick in revenue and adjusted EBITDA in the second quarter of 2024, indicating steady growth across all business segments. Sterigenics, Sotera Health's major segment, experienced a revenue increase due to pricing benefits and volume advantages, while Nordion's revenue saw a significant 29% rise. Nelson Labs also continued its growth trajectory.